CEBPA exerts a specific and biologically important proapoptotic role in pancreatic β cells through its downstream network targets

Molecular Biology of the Cell

Volumn 25, Issue 16, 2014, Pages 2333-2341

  Barbagallo, Davide ^a   Condorelli, Angelo Giuseppe ^a   Piro, Salvatore ^a   Parrinello, Nunziatina ^a   Flyøel, Tina ^b   Ragusa, Marco ^a   Rabuazzo, Agata Maria ^a   Strøling, Joachim ^b   Purrello, Francesco ^a   Di Pietro, Cinzia ^a   Purrello, Michele ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CEBPA; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; COMPUTER MODEL; CYTOKINE RESPONSIVE ELEMENT; GENE SILENCING; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL LINE; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905977527     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-02-0703     Document Type: Article

References (47)

1. Allagnat F, Fukaya M, Nogueira TC, Delaroche D, Welsh N, Marselli L, Marchetti P, Haefliger JA, Eizirik DL, Cardozo AK (2012). C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in β-cells. Cell Death Differ 19, 1836-1846.
2. Anello M, Spampinato D, Piro S, Purrello F, Rabuazzo AM (2004). Glucosamine-induced alterations of mitochondrial function in pancreatic beta-cells: possible role of protein glycosylation. Am J Physiol Endocrinol Metab 287, E602-608. (Pubitemid 39237886)
3. Barbagallo D et al. (2013). miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells. BMC Genomics 14, 62.
4. Bramswig NC, Everett LJ, Schug J, Dorrell C, Liu C, Luo Y, Streeter PR, Naji A, Grompe M, Kaestner KH (2013). Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest 123, 1275-1284.
5. Cole SW, Yan W, Galic Z, Arevalo J, Zack JA (2005). Expression-based monitoring of transcription factor activity: the TELiS database. Bioinformatics 21, 803-810. (Pubitemid 40439417)
6. Darville MI, Eizirik DL (2006). Notch signaling: a mediator of beta-cell de-differentiation in diabetes? Biochem Biophys Res Commun 339, 1063-1068. (Pubitemid 41790572)
7. Davis FP, Eddy SR (2013). Transcription factors that convert adult cell identity are differentially polycomb repressed. PLoS One 8, e63407.
8. Di Gialleonardo V, de Vries EF, Di Girolamo M, Quintero AM, Dierckx RA, Signore A (2012). Imaging of β-cell mass and insulitis in insulin-dependent (type 1) diabetes mellitus. Endocr Rev 33, 892-919.
9. Di Pietro C et al. (2009). The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma. BMC Med Genomics 2, 20.
10. Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T (2008). Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 29, 334-350. (Pubitemid 351679703)
11. Eizirik DL, Colli ML, Ortis F (2009). The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5, 219-226.
12. Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JEMouse Genome Database Group (2012). The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res 40, D881-D886.
13. Eyholzer M, Schmid S, Wilkens L, Mueller BU, Pabst T (2010). The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer 103, 275-284.
14. Friedman AD, Keefer JR, Kummalue T, Liu H, Wang QF, Cleaves R (2003). Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha. Blood Cells Mol Dis 31, 338-341. (Pubitemid 37433874)
15. Fuchs O, Kostecka A, Provazníková D, Krásná B, Kotlín R, Stanková M, Kobylka P, Dostálová G, Zeman M, Chochola M (2010). CCAAT/enhancer-binding protein alpha (CEBPA) polymorphisms and mutations in healthy individuals and in patients with peripheral artery disease, ischaemic heart disease and hyperlipidaemia. Folia Biol (Praha) 56, 51-57.
16. Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP (2005). Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 106, 2827-2836. (Pubitemid 41510760)
17. Hansen JB et al. (2012). Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic β cell fate in response to cytokines. Cell Metab 16, 449-461.
18. Huang DW, Sherman BT, Lempicki RA (2009). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37, 1-13.
19. Johnson PF, Landschulz WH, Graves BJ, McKnight SL (1987). Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev 1, 133-146.
20. Lee C, Huang CH (2013). LASAGNA: a novel algorithm for transcription factor binding site alignment. BMC Bioinformatics 14, 108.
21. Lee Y et al. (2013). Network models of genome-wide association studies uncover the topological centrality of protein interactions in complex diseases. J Am Med Inform Assoc 20, 619-629.
22. Lin CY, Chin CH, Wu HH, Chen SH, Ho CW, Ko MT (2008). Hubba: hub objects analyzer - a framework of interactome hubs identification for network biology. Nucleic Acids Res 36, W438-W443.
23. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. (Pubitemid 34164012)
24. Lo KA, Bauchmann MK, Baumann AP, Donahue CJ, Thiede MA, Hayes LS, des Etages SA, Fraenkel E (2011). Genome-wide profiling of H3K56 acetylation and transcription factor binding sites in human adipocytes. PLoS One 6, e19778.
25. Lynn DJ et al. (2008). InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol 4, 218.
26. Moore F, Santin I, Nogueira TC, Gurzov EN, Marselli L, Marchetti P, Eizirik DL (2012). The transcription factor C/EBP delta has anti-apoptotic and anti-inflammatory roles in pancreatic beta cells. PLoS One 7, e31062.
27. Nerlov C (2007). The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 17, 318-324.
28. Ortis F et al. (2010). Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells. Diabetes 59, 358-374.
29. Ou D, Metzger DL, Wang X, Huang J, Pozzilli P, Tingle AJ (2002). TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction. Diabetologia 45, 1678-1688. (Pubitemid 35478137)
30. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L (2004). ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32, W280-W286. (Pubitemid 38997344)
31. Paz-Priel I, Friedman A (2011). C/EBPα dysregulation in AML and ALL. Crit Rev Oncog 16, 93-102.
32. Pulikkan JA et al. (2010). C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 116, 5638-5649.
33. Ragusa M et al. (2012). Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors. J Mol Med (Berl) 90, 1421-1438.
34. Sarkar SA, Kutlu B, Velmurugan K, Kizaka-Kondoh S, Lee CE, Wong R, Valentine A, Davidson HW, Hutton JC, Pugazhenthi S (2009). Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia 52, 1092-1101.
35. Schaffer AE et al. (2013). Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity. PLoS Genet 9, e1003274.
36. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-2504. (Pubitemid 37428274)
37. Smyth GK (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article 3.
38. Talchai C, Xuan S, Lin HV, Susse IL, Accili D (2012). Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell 150, 1223-1234.
39. Tsukada J, Yoshida Y, Kominato Y, Auron PE (2011). The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54, 6-19.
40. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.
41. Vento MT, Zazzu V, Loffreda A, Cross JR, Downward J, Stoppelli MP, Iaccarino I (2010). Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells. PLoS One 5, e15636.
42. Wang D, Paz-Priel I, Friedman AD (2009). NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil production. J Immunol 182, 5757-5762.
43. Wang GL, Shi X, Salisbury E, Timchenko NA (2008). Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines. Exp Cell Res 314, 1626-1639.
44. Wang X, Huang G, Mei S, Qian J, Ji J, Zhang J (2009). Over-expression of C/EBP-alpha induces apoptosis in cultured rat hepatic stellate cells depending on p53 and peroxisome proliferator-activated receptor-gamma. Biochem Biophys Res Commun 380, 286-291.
45. Yoshida H, Imamura T, Fujiki A, Hirashima Y, Miyachi M, Inukai T, Hosoi H (2012). Post-transcriptional modulation of C/EBPα prompts monocytic differentiation and apoptosis in acute myelomonocyticleukaemia cells. Leuk Res 36, 735-741.
46. Zhang H et al. (2013). Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia. Cancer Cell 24, 575-588.
47. Zhang HM, Chen H, Liu W, Liu H, Gong J, Wang H, Guo AY (2012). AnimalTFDB: a comprehensive animal transcription factor database. Nucleic Acids Res 40, D144-D149.